ALVO Latest Press Releases

-- January 22, 2026 --

ROSEN, NATIONAL INVESTOR COUNSEL, Encourages Alvotech Investors to Inquire About Securities Class Action Investigation - ALVO Newsfile 5:26 PM

-- January 20, 2026 --

Rosen Law Firm Encourages Alvotech Investors to Inquire About Securities Class Action Investigation - ALVO PRNewswire 5:30 PM

-- January 18, 2026 --

ROSEN, SKILLED INVESTOR COUNSEL, Encourages Alvotech Investors to Inquire About Securities Class Action Investigation - ALVO Newsfile 11:46 AM

-- January 17, 2026 --

ROSEN, LEADING TRIAL ATTORNEYS, Encourages Alvotech Investors to Inquire About Securities Class Action Investigation - ALVO Newsfile 10:14 AM

-- January 15, 2026 --

Rosen Law Firm Encourages Alvotech Investors to Inquire About Securities Class Action Investigation - ALVO PRNewswire 6:35 PM

-- January 14, 2026 --

ALVO INVESTOR ALERT: Hagens Berman Investigates Alvotech (ALVO) for Potential Securities Fraud Following Massive FDA-Induced Stock Crash PRNewswire 2:30 PM

-- January 13, 2026 --

Bragar Eagel & Squire, P.C. Continues Investigations into Alvotech and Beyond Meat on Behalf of Stockholders and Encourages Investors to Contact the Firm Globe Newswire 3:22 PM

-- January 10, 2026 --

Alvotech Investor News: Rosen Law Firm Encourages Alvotech Investors to Inquire About Securities Class Action Investigation - ALVO PRNewswire 12:56 PM

-- January 6, 2026 --

Alvotech announces planned CEO succession and leadership transition Globe Newswire 7:15 AM

-- January 5, 2026 --

ALVO Investigation: Investors Encouraged to Contact Kirby McInerney LLP Business Wire 6:00 PM

Alvotech Investor News: Rosen Law Firm Encourages Alvotech Investors to Inquire About Securities Class Action Investigation - ALVO PRNewswire 1:00 AM

-- December 31, 2025 --

Alvotech Secures Term Loan Facility of USD 100 Million Globe Newswire 4:30 PM

-- December 30, 2025 --

Alvotech Investor News: Rosen Law Firm Encourages Alvotech Investors to Inquire About Securities Class Action Investigation - ALVO PRNewswire 7:06 PM

-- December 25, 2025 --

Alvotech Investor News: Rosen Law Firm Encourages Alvotech Investors to Inquire About Securities Class Action Investigation - ALVO PRNewswire 12:59 PM

-- December 23, 2025 --

ALVO Investor News: If You Have Suffered Losses in Alvotech (NASDAQ: ALVO), You Are Encouraged to Contact The Rosen Law Firm About Your Rights Globe Newswire 11:45 PM

-- December 22, 2025 --

Alvotech announces European launch of first-in-market biosimilar to Simponi (golimumab) globally by partner Advanz Pharma Globe Newswire 2:00 AM

-- December 19, 2025 --

Alvotech Investor News: Rosen Law Firm Encourages Alvotech Investors to Inquire About Securities Class Action Investigation - ALVO PRNewswire 6:54 PM

Alvotech and Teva Secure U.S. Settlement Date for AVT06, a Proposed Biosimilar to Eylea Globe Newswire 3:30 AM

-- December 17, 2025 --

Alvotech (ALVO) Faces Investor Scrutiny Amid Manufacturing Deficiencies Severely Impacting Assurances of 2025 Revenues and Adjusted EBITDA, Stock Tumbles 33% -- Hagens Berman PRNewswire 4:08 PM

-- December 15, 2025 --

Bragar Eagel & Squire, P.C. Continues Investigations into Beyond Meat and Alvotech on Behalf of Stockholders and Encourages Investors to Contact the Firm Globe Newswire 4:24 PM

-- December 13, 2025 --

Alvotech Investor News: Rosen Law Firm Encourages Alvotech Investors to Inquire About Securities Class Action Investigation - ALVO PRNewswire 8:48 AM

-- December 11, 2025 --

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Alvotech - ALVO PRNewswire 10:00 AM

Alvotech (ALVO) Faces Investor Scrutiny Amid Manufacturing Deficiencies Severely Impacting Assurances of 2025 Revenues and Adjusted EBITDA, Stock Tumbles 33% -- Hagens Berman PRNewswire 9:30 AM

-- December 8, 2025 --

Rosen Law Firm Encourages Alvotech Investors to Inquire About Securities Class Action Investigation - ALVO PRNewswire 8:26 PM

-- December 6, 2025 --

ALVO Investor News: If You Have Suffered Losses in Alvotech (NASDAQ: ALVO), You Are Encouraged to Contact The Rosen Law Firm About Your Rights Globe Newswire 2:55 PM

-- December 4, 2025 --

Rosen Law Firm Encourages Alvotech Investors to Inquire About Securities Class Action Investigation - ALVO Business Wire 1:20 PM

-- December 2, 2025 --

Alvotech (ALVO) Faces Investor Scrutiny Amid Manufacturing Deficiencies Severely Impacting Assurances of 2025 Revenues and Adjusted EBITDA, Stock Tumbles 33% -- Hagens Berman PRNewswire 8:10 PM

-- November 24, 2025 --

Alvotech Announces Approval of AVT03, a Biosimilar to Prolia and Xgeva (denosumab) in the European Economic Area Globe Newswire 5:30 AM

-- November 22, 2025 --

Bragar Eagel & Squire, P.C. Continues Investigations into Regencell, Beyond Meat, Alvotech, and Camping World on Behalf of Stockholders and Encourages Investors to Contact the Firm Globe Newswire 11:04 AM

-- November 20, 2025 --

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Alvotech - ALVO PRNewswire 10:00 AM

Alvotech and Advanz Pharma Receive Marketing Approval Across the European Economic Area for Gobivaz, a First-in-Market Biosimilar to Simponi (golimumab) Globe Newswire 4:00 AM

-- November 19, 2025 --

ALVO Investigation: Investors Encouraged to Contact Kirby McInerney LLP Business Wire 8:00 PM

-- November 13, 2025 --

Alvotech (ALVO) Faces Investor Scrutiny Amid Manufacturing Deficiencies Severely Impacting Assurances of 2025 Revenues and Adjusted EBITDA, Stock Tumbles 33% -- Hagens Berman PRNewswire 9:06 AM

-- November 12, 2025 --

Bragar Eagel & Squire, P.C. Is Investigating Regencell, Beyond Meat, Alvotech, and Camping World and Encourages Investors to Contact the Firm Globe Newswire 5:01 PM

Alvotech Reports Results for the First Nine Months of 2025 and Provides a Business Update Globe Newswire 4:40 PM

Alvotech (ALVO) Faces Investor Scrutiny Amid Manufacturing Deficiencies Severely Impacting Assurances of 2025 Revenues and Adjusted EBITDA, Stock Tumbles 33% -- Hagens Berman Globe Newswire 1:26 PM

-- November 10, 2025 --

INVESTIGATION ALERT: Edelson Lechtzin LLP Announces Investigation of Alvotech (NASDAQ: ALVO) and Encourages Investors with Substantial Losses to Contact the Firm PRNewswire 8:15 PM

Scott+Scott Attorneys at Law LLP Reminds Investors of Its Investigation into Alvotech (NASDAQ: ALVO) Globe Newswire 5:28 PM

UK High Court Rules in Favor of Alvotech Paving Way for Manufacture and Market Entry of AVT06, biosimilar to Eylea (aflibercept) Globe Newswire 4:00 AM

-- November 6, 2025 --

Scott+Scott Attorneys at Law LLP Alerts Investors of Its Investigation into Alvotech (NASDAQ: ALVO) Globe Newswire 6:28 PM

Alvotech and Advanz Pharma Receive Marketing Authorisations for Gobivaz, a Biosimilar to Simponi (golimumab), from the MHRA Globe Newswire 9:07 AM

-- November 5, 2025 --

ALVOTECH ALERT: Bragar Eagel & Squire, P.C. is Investigating Alvotech on Behalf of Alvotech Stockholders and Encourages Investors to Contact the Firm Globe Newswire 12:26 PM

-- November 4, 2025 --

Alvotech INVESTIGATION: Kirby McInerney LLP Announces Investigation Into Potential Securities Fraud on behalf of Investors (ALVO) Globe Newswire 8:00 PM

Alvotech Announces Webcast on November 13, 2025 to Report Financial Results for the First Nine Months of 2025 and Provide a Business Update Globe Newswire 4:01 PM

-- November 3, 2025 --

ALVO Investor ALERT: Block & Leviton Investigating Alvotech for Securities Fraud; Investors Should Contact the Firm to Potentially Recover Losses Globe Newswire 4:02 PM

-- November 2, 2025 --

Alvotech Provides Update on the Status of U.S. Biologics License Application for AVT05 Globe Newswire 5:12 PM

-- October 22, 2025 --

Alvotech Announces Changes in Global Business Development and Commercial Operations Team Globe Newswire 5:00 AM

-- October 6, 2025 --

Kashiv Biosciences Announces Submission of Biologics License Application to U.S. FDA and Acceptance of Market Authorization Application by European Medicines Agency for ADL-018, a Proposed Biosimilar to XOLAIR (omalizumab) Business Wire 8:00 AM

European Marketing Application for AVT23, a Proposed Biosimilar to Xolair (omalizumab), Accepted by the European Medicines Agency Globe Newswire 4:40 AM

-- September 22, 2025 --

European Medicines Agency Recommends Marketing Authorization of AVT03, Alvotech's Proposed Biosimilar to Prolia and Xgeva Globe Newswire 6:15 AM

European Medicines Agency Recommends Marketing Approval of Gobivaz, Alvotech's Proposed Biosimilar to Simponi (golimumab) with Advanz Pharma as Commercialization Partner Globe Newswire 4:30 AM

-- September 19, 2025 --

Alvotech Announces Marketing Approval in Japan of Three New Biosimilars Globe Newswire 7:45 AM

-- September 4, 2025 --

Alvotech Meets Investors and Participates in a Fireside Chat at the Morgan Stanley 23rd Annual Global Healthcare Conference in New York Globe Newswire 9:15 AM

-- August 31, 2025 --

Alvotech's Earnings Call: Strong Growth Amid Challenges TipRanks 10:08 PM